Log in to save to my catalogue

Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mo...

Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mo...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10293910

Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality

About this item

Full title

Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality

Publisher

United States: American Medical Association

Journal title

JAMA network open, 2023-06, Vol.6 (6), p.e2320222-e2320222

Language

English

Formats

Publication information

Publisher

United States: American Medical Association

More information

Scope and Contents

Contents

Given the burden of chronic liver disease on the health care system, more information on the hepatoprotective association of statins in the general population is needed.
To examine whether regular statin use is associated with a reduction in liver disease, particularly hepatocellular carcinoma (HCC) and liver-related deaths, in the general popul...

Alternative Titles

Full title

Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10293910

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10293910

Other Identifiers

ISSN

2574-3805

E-ISSN

2574-3805

DOI

10.1001/jamanetworkopen.2023.20222

How to access this item